S100B and myeloid sarcoma: Camponeschi et al. demonstrated that the inhibitor of astrocytic S100B synthesis with arundic acid in the MS animal model, a significant reduction of astrogliosis, demyelination, proinflammatory cytokine expression were recognized14).